title: Effects of the human CD38 glycoprotein on the early stages of the HIV-1 replication cycle.
abstract: CD38 displays lateral association with the HIV-1 receptor CD4. This association is potentiated by the HIV-1 envelope glycoprotein gp120. The aim of this work was to evaluate the CD38 role in T cell susceptibility to HIV-1 infection. Using laboratory X4 HIV-1 strains and X4 and X4/R5 primary isolates, we found that CD38 expression was negatively correlated to cell susceptibility to infection, evaluated as percentage of infected cells, release of HIV p24 in the supernatants, and cytopathogenicity. This correlation was at first suggested by results obtained in a panel of human CD4(+) T cell lines expressing different CD38 levels (MT-4, MT-2, C8166, CEMx174, Supt-1, and H9) and then demonstrated using CD38 transfectants of MT-4 cells (the line with the lowest CD38 expression). To address whether CD38 affected viral binding, we used mouse T cells that are non-permissive for productive infection. Gene transfection in mouse SR.D10.CD4(-).F1 T cells produced four lines expressing human CD4 and/or CD38. Ability of CD4(+)CD38(+)cells to bind HIV-1 or purified recombinant gp120 was significantly lower than that of CD4(+)CD38(-) cells. These data suggest that CD38 expression inhibits lymphocyte susceptibility to HIV infection, probably by inhibiting gp120/CD4-dependent viral binding to target cells.-Savarino, A., Bottarel, F., Calosso, L., Feito, M. J., Bensi, T., Bragardo, M., Rojo, J. M., Pugliese, A., Abbate, I., Capobianchi, M. R., Dianzani, F., Malavasi, F., and Dianzani, U. Effects of the human CD38 glycoprotein on the early stages of theHIV-1 replication cycle.
authors.affiliation: Department of Medical and Surgical Sciences, University of Turin, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Savarino
authors.forename: F
authors.initials: F
authors.lastname: Bottarel
authors.forename: L
authors.initials: L
authors.lastname: Calosso
authors.forename: M J
authors.initials: MJ
authors.lastname: Feito
authors.forename: T
authors.initials: T
authors.lastname: Bensi
authors.forename: M
authors.initials: M
authors.lastname: Bragardo
authors.forename: J M
authors.initials: JM
authors.lastname: Rojo
authors.forename: A
authors.initials: A
authors.lastname: Pugliese
authors.forename: I
authors.initials: I
authors.lastname: Abbate
authors.forename: M R
authors.initials: MR
authors.lastname: Capobianchi
authors.forename: F
authors.initials: F
authors.lastname: Dianzani
authors.forename: F
authors.initials: F
authors.lastname: Malavasi
authors.forename: U
authors.initials: U
authors.lastname: Dianzani
mesh_terms: D036541:ADP-ribosyl Cyclase; D051997:ADP-ribosyl Cyclase 1; D000818:Animals; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000235:genetics / Q000502:physiology*; D015704:CD4 Antigens / Q000235:genetics / Q000378:metabolism; D015497:HIV-1 / Q000378:metabolism / Q000502:physiology*; D006801:Humans; D008562:Membrane Glycoproteins; D051379:Mice; D009244:NAD+ Nucleosidase / Q000235:genetics / Q000502:physiology*; D010641:Phenotype; D013601:T-Lymphocytes / Q000821:virology*; D014162:Transfection; D014407:Tumor Cells, Cultured; D014779:Virus Replication
chemical_list: D015703:Antigens, CD; D000943:Antigens, Differentiation; D015704:CD4 Antigens; D008562:Membrane Glycoproteins; D036541:ADP-ribosyl Cyclase; C498154:CD38 protein, human; C498155:Cd38 protein, mouse; D009244:NAD+ Nucleosidase; D051997:ADP-ribosyl Cyclase 1